Search results for "Ladder"

showing 10 items of 674 documents

Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.

2019

The sonic hedgehog (SHH) signaling pathway plays an integral role in the maintenance and progression of bladder cancer (BCa) and SHH inhibition may be an efficacious strategy for BCa treatment. We assessed an in-house human BCa tissue microarray and found that the SHH transcription factors, GLI1 and GLI2, were increased in disease progression. A panel of BCa cell lines show that two invasive lines, UM-UC-3 and 253J-BV, both express these transcription factors but UM-UC-3 produces more SHH ligand and is less responsive in viability to pathway stimulation by recombinant human SHH or smoothened agonist, and less responsive to inhibitors including the smoothened inhibitors cyclopamine and SANT-…

0301 basic medicineanimal structuresCyclopaminePhysiologyCell Survivalmedicine.medical_treatmentClinical BiochemistryAntineoplastic AgentsZinc Finger Protein Gli2Targeted therapy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineGLI1GLI2Cell Line TumormedicineHumansSonic hedgehogskin and connective tissue diseasesTranscription factorbiologyChemistryCell CycleNuclear ProteinsCell Biology3. Good healthGene Expression Regulation Neoplastic030104 developmental biologyUrinary Bladder Neoplasms030220 oncology & carcinogenesisbiology.proteinCancer researchSignal transductionSmoothenedJournal of cellular physiology
researchProduct

Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction

2020

Cisplatin, which induces DNA damage, is standard chemotherapy for advanced bladder cancer (BCa). However, efficacy is limited due to resistance development. Since artesunate (ART), a derivative of artemisinin originating from Traditional Chinese Medicine, has been shown to exhibit anti-tumor activity, and to inhibit DNA damage repair, the impact of artesunate on cisplatin-resistant BCa was evaluated. Cisplatin-sensitive (parental) and cisplatin-resistant BCa cells, RT4, RT112, T24, and TCCSup, were treated with ART (1&ndash

0301 basic medicineautophagyRMCell cycle checkpointDNA RepairDNA damageArtesunateCell Cycle ProteinsArticlegrowth inhibition03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCell Line TumormedicineHumansddc:610Medicine Chinese Traditionalskin and connective tissue diseaseslcsh:QH301-705.5Cell ProliferationCisplatinartesunate (ART)Cell growthAutophagyapoptosisGeneral MedicineCell cycleG1 Phase Cell Cycle Checkpoints030104 developmental biologychemistrylcsh:Biology (General)Urinary Bladder NeoplasmsApoptosisDrug Resistance Neoplasm030220 oncology & carcinogenesisCancer researchbladder cancer (BCa)Growth inhibitioncisplatin resistanceMicrotubule-Associated Proteinsmedicine.drug
researchProduct

Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?

2021

The search for new diagnostic tests for cancer or ways to improve existing tests is primarily driven by the desire to identify the disease as early as possible. In this report, we summarize the current knowledge of the most promising diagnostic protein bladder cancer (BC) markers reported over the last decade. Unfortunately, analysis of published data suggests that a reliable, highly sensitive biomarker test-system based on ELISA for detecting BC has not yet been developed. The use of more sensitive assays to detect ultra-low concentrations of biomarkers not available for ELISA, could be very beneficial. Based on the literature and pilot experimental data, we conclude that a highly sensitiv…

0301 basic medicinemagnetic labelsMicroarrayProtein biomarkersComputational biologyBiochemistry Genetics and Molecular Biology (miscellaneous)Biochemistry03 medical and health sciences0302 clinical medicinemedicineMolecular Biosciencesimmunoassaylcsh:QH301-705.5Molecular BiologyBladder cancermedicine.diagnostic_testbusiness.industryCancerDiagnostic testprotein biomarkersmedicine.diseaseHighly sensitive030104 developmental biologylcsh:Biology (General)030220 oncology & carcinogenesisImmunoassayPerspectivebladder cancerBiomarker (medicine)businessmicroarrayFrontiers in Molecular Biosciences
researchProduct

<p>The microbiota of the bilio-pancreatic system: a cohort, STROBE-compliant study</p>

2019

Background: The gut microbiota play an essential role in protecting the host against pathogenic microorganisms by modulating immunity and regulating metabolic processes. In response to environmental factors, microbes can hugely alter their metabolism. These factors can substantially impact the host and have potential pathologic implications. Particularly pathogenic microorganisms colonizing pancreas and biliary tract tissues may be involved in chronic inflammation and cancer evolution. Purpose: To evaluate the effect of bile microbiota on survival in patients with pancreas and biliary tract disease (PBD). Patients and Methods: We investigated 152 Italian patients with cholelithiasis (CHL), …

0301 basic medicinemedicine.medical_specialty030106 microbiologyGut floraGastroenterology03 medical and health sciences0302 clinical medicineImmunityInternal medicineCarcinomaMedicinePharmacology (medical)030212 general & internal medicinePharmacologybiologybusiness.industryGallbladderCancermedicine.diseasebiology.organism_classificationInfectious Diseasesmedicine.anatomical_structureBiliary tractPancreatitisbusinessPancreasInfection and Drug Resistance
researchProduct

ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract development

2017

AbstractPreviously genome-wide association methods in patients with classic bladder exstrophy (CBE) found association with ISL1, a master control gene expressed in pericloacal mesenchyme. This study sought to further explore the genetics in a larger set of patients following-up on the most promising genomic regions previously reported. Genotypes of 12 markers obtained from 268 CBE patients of Australian, British, German Italian, Spanish and Swedish origin and 1,354 ethnically matched controls and from 92 CBE case-parent trios from North America were analysed. Only marker rs6874700 at the ISL1 locus showed association (p = 2.22 × 10−08). A meta-analysis of rs6874700 of our previous and prese…

0301 basic medicinemedicine.medical_specialtyPathologyMesenchymeUrinary systemOrganogenesisLIM-Homeodomain ProteinsLocus (genetics)030105 genetics & heredityBiologyPolymorphism Single Nucleotidebladder extrophyArticlePronephrosMesoderm03 medical and health sciencesMiceBEEC bladder extrophy urinary tract development ISL1GenotypemedicineAnimalsHumansProtein IsoformsGenetic Predisposition to DiseaseBEECUrinary TractGeneZebrafishGeneticsMultidisciplinaryBladder ExstrophyGene Expression Regulation DevelopmentalISL1medicine.diseaseEmbryo Mammalianurinary tract developmentBladder exstrophy030104 developmental biologymedicine.anatomical_structureReconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10]LarvaISL1Medical geneticsFemaleTranscription FactorsRare cancers Radboud Institute for Health Sciences [Radboudumc 9]Scientific Reports
researchProduct

Urinary Bladder Weight and Function in a Rat Model of Mild Hyperglycemia and Its Treatment With Dapagliflozin

2019

Hypertrophy and dysfunction of the urinary bladder are consistently observed in animal models of type 1 and less consistently in those of type 2 diabetes. We have tested the effects of mild hyperglycemia (n = 10 per group) in a randomized, blinded study and, in a blinded pilot study, of type 2 diabetes (n = 6 per group) and its treatment with dapagliflozin (1 mg/kg per day) on weight, contraction, and relaxation of the rat bladder. Based on a combination of high-fat diet and a low dose of streptozotocin, animals in the main study reached a mean peak blood glucose level of about 300 mg/dl, which declined to 205 mg/dl at study end. This was associated with a small, if any, increase in bladder…

0301 basic medicinemedicine.medical_specialtyType 2 diabetesMuscle hypertrophyContractility03 medical and health scienceschemistry.chemical_compound0302 clinical medicinerelaxationDiabetes mellitusInternal medicineMedicinePharmacology (medical)DapagliflozinFenoterolOriginal ResearchPharmacologyUrinary bladderdiabetesbusiness.industrylcsh:RM1-950contractionmedicine.diseaseStreptozotocin030104 developmental biologymedicine.anatomical_structureEndocrinologylcsh:Therapeutics. Pharmacologychemistry030220 oncology & carcinogenesishyperglycemiabusinesshypertrophyurinary bladdermedicine.drugFrontiers in Pharmacology
researchProduct

“New Kids on the Block” — The Game Changers. The Role of Immune Check Point Blockade in Personalised Treatment of Prostate, Urinary Bladder and Kidne…

2021

Abstract Early detection and diagnosis of cancer followed by a personalised approach to treatment is a key and can save lives. It has been an important issue in both the medical and social fields. The search for instruments and/or diagnostics tools able to detect cancers at an early stage has led to consideration of the usage of various approaches, such as exhaled air, biomarkers in blood, urine testing as well as imaging techniques. This actual time and everything that is happening around us could be characterised as a strange and very unpredictable time. This comparison could be made not only due to the actual coronavirus situation, but also the same can be noticed in the personalised med…

0301 basic medicinemedicine.medical_specialtyUrinary bladderbusiness.industryUrologymedicine.diseaseBlockade03 medical and health sciences030104 developmental biology0302 clinical medicinemedicine.anatomical_structureImmune systemProstate030220 oncology & carcinogenesisBlock (telecommunications)medicinebusinessKidney cancerCheck pointProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
researchProduct

Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data

2021

Background: Syndecan-1 (CD138

<i>SDC1</i>Pathologymedicine.medical_specialtyanimal structuresArticleSyndecan 1SDC103 medical and health sciences0302 clinical medicinemedicineLymph nodeIntrahepatic Cholangiocarcinoma030304 developmental biology0303 health sciencesbusiness.industryGallbladderRCancersyndecan-1General Medicinemedicine.diseasecarbohydrates (lipids)medicine.anatomical_structure030220 oncology & carcinogenesisBiliary Intraepithelial NeoplasiaMedicineImmunohistochemistrybiomarkerPancreasbusinesscholangiocarcinomaJournal of Clinical Medicine
researchProduct

Laparoscopic management of cholecystocolonic fistula: A case report and a brief literature review

2020

Highlights • Cholecystoenteric fistula is a rare and late complication of cholelithiasis. • We report a case of cholecysto-colonic fistula with hepatic flexure management by laparoscopic approach, a 64 years old male patients with fever of an unknown origins for two months and abdominal pain. • We performed laparoscopic cholecystectomy and repaired colonic wall with intra-corporeal sutures. • The laparoscopic management of cholecystoeneteric fistula is a feasible and safe procedure but the operative strategy should be individualized.

Abdominal painmedicine.medical_specialtymedicine.medical_treatmentFistulaColonoscopyComplicated cholelithiasisArticle03 medical and health sciences0302 clinical medicineMedicineLaparoscopySurgical teammedicine.diagnostic_testbusiness.industryGallbladderGeneral surgerymedicine.diseasemedicine.anatomical_structureCholecystocolonic fistula030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgeryCholecystectomyLaparoscopyPresentation (obstetrics)medicine.symptombusinessComplicated cholelithiasiInternational Journal of Surgery Case Reports
researchProduct

Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience

2017

Objective To evaluate the long-term outcomes in patients with classic bladder exstrophy and continent anal urinary diversion (CAD) for continence, upper urinary tract status, secondary malignancies, and sexual function. Patients and Methods The medical records of 82 exstrophy patients having undergone CAD in our department between 1970 and 2015 were reviewed. Patients were invited for follow-up examinations and asked to complete validated questionnaires relating to sexual function. Results Thirty-two of 57 eligible patients with a median follow-up of 23.9 years were included in the study. Ninety-seven percent of patients were fully continent during daytime. Upper urinary tract and renal fun…

AdenomaAdultMalemedicine.medical_specialtyTime FactorsSexual BehaviorUrologymedicine.medical_treatmentUrinary system030232 urology & nephrologyAdenocarcinomaUrinary DiversionYoung Adult03 medical and health sciencesPostoperative Complications0302 clinical medicineSurveys and QuestionnairesInternal medicinemedicineHumansRetrospective StudiesUpper urinary tractmedicine.diagnostic_testbusiness.industryMedical recordBladder ExstrophyUrinary Reservoirs ContinentUrinary diversionMiddle Agedmedicine.diseaseSurgeryEndoscopyBladder exstrophyTreatment OutcomeSexual dysfunctionUrinary Bladder Neoplasms030220 oncology & carcinogenesisColonic NeoplasmsFemalemedicine.symptombusinessSexual functionFollow-Up StudiesUrology
researchProduct